Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial ScienceDirect Cagrilintide is a novel, long acting peptide designed to target multiple receptors involved in appetite regulation and energy balance. Unlike traditional weight loss medications that often target a single pathway, cagrilintide acts as CAGRILINTIDE PEPTIDE 5MG 10MG VIAL UMBRELLA Labs Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed Emerging incretin and multi agonist based treatments the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio kidney liver metabolic diseases and beyond Metabolism Clinical and Experimental Cagrilintide: Effective Weekly Dosage and Weight Loss Benefits Explained